CIK 0001768224
- Accelerated filer
- Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 858-900-2660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $42.95 ($429,500)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $54.23 ($542,300)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $75.31 ($753,100)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $46.40 ($464,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 800,000 shares at an average $100.81 ($80,650,635)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $96.19 ($961,900)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $55.28 ($552,800)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $42.83 ($428,300)
- 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $45.16 ($451,600)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 6 of 8 · 149 filings